Literature DB >> 7964513

Trimming of antigenic peptides in an early secretory compartment.

H L Snyder1, J W Yewdell, J R Bennink.   

Abstract

Major histocompatibility complex (MHC) class I molecules bind peptides of 8-10 residues in the endoplasmic reticulum (ER) and convey them to the cell surface for inspection by CD8-expressing T cells (TCD8+). Antigenic peptides are predominantly derived from a cytosolic pool of polypeptides. The proteolytic generation of peptides from polypeptides clearly begins in the cytosol, but it is uncertain whether the final proteolytic steps occur before or after peptides are transported into the ER by the MHC-encoded peptide transporter (TAP). To study the trimming of antigenic peptides in the secretory pathway in the absence of cytosolic processing, we used an NH2-terminal signal sequence to target to the ER of TAP-deficient cells, "tandem" peptides consisting of two defined TCD8+ determinants arranged from head to tail. We find that in contrast to cytosolic proteases in TAP-expressing cells, which are able to liberate antigenic peptides from either end of a tandem peptide, proteases (probably aminopeptidases) present in an early secretory compartment preferentially liberate the COOH-terminal determinant. These findings demonstrate that proteolytic activities associated with antigen processing are not limited to the cytosol, but that they also exist in an early secretory compartment. Such secretory aminopeptidases may function to trim TAP-transported peptides to the optimal size for binding to class I molecules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964513      PMCID: PMC2191784          DOI: 10.1084/jem.180.6.2389

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.

Authors:  M Gaczynska; K L Rock; A L Goldberg
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

2.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective.

Authors:  J C Shepherd; T N Schumacher; P G Ashton-Rickardt; S Imaeda; H L Ploegh; C A Janeway; S Tonegawa
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

3.  Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.

Authors:  M Mackett; T Yilma; J K Rose; B Moss
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

4.  A subset of HLA-B27 molecules contains peptides much longer than nonamers.

Authors:  R G Urban; R M Chicz; W S Lane; J L Strominger; A Rehm; M J Kenter; F G UytdeHaag; H Ploegh; B Uchanska-Ziegler; A Ziegler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter.

Authors:  J J Neefjes; F Momburg; G J Hämmerling
Journal:  Science       Date:  1993-08-06       Impact factor: 47.728

6.  TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide.

Authors:  I Bacik; J H Cox; R Anderson; J W Yewdell; J R Bennink
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

7.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

8.  Peptide size selection by the major histocompatibility complex-encoded peptide transporter.

Authors:  F Momburg; J Roelse; G J Hämmerling; J J Neefjes
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

9.  Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator.

Authors:  T N Schumacher; D V Kantesaria; M T Heemels; P G Ashton-Rickardt; J C Shepherd; K Fruh; Y Yang; P A Peterson; S Tonegawa; H L Ploegh
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes.

Authors:  B Boes; H Hengel; T Ruppert; G Multhaup; U H Koszinowski; P M Kloetzel
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  39 in total

1.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Getting peptide vaccines to work: just a matter of quality control?

Authors:  Esteban Celis
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.

Authors:  Robert L Ferris; Jennifer L Hunt; Soldano Ferrone
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.

Authors:  Victor H Engelhard
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

5.  Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.

Authors:  R Khanna; S R Burrows; D J Moss; S L Silins
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide.

Authors:  A Craiu; T Akopian; A Goldberg; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells.

Authors:  P M Day; J W Yewdell; A Porgador; R N Germain; J R Bennink
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 8.  Thiol oxidation and reduction in MHC-restricted antigen processing and presentation.

Authors:  P Cresswell; B Arunachalam; N Bangia; T Dick; G Diedrich; E Hughes; M Maric
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

9.  Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.

Authors:  L M Mylin; R H Bonneau; J D Lippolis; S S Tevethia
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.